Dow Up 0.26% Nasdaq Down 1.07%

Novavax, Inc. (NVAX)

-NasdaqGS
4.52 0.24(5.04%)
Prev Close:4.76
Open:N/A
Bid:4.50 x 600
Ask:N/A
1y Target Est:10.40
Beta:1.04
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.51 - 4.78
52wk Range:2.68 - 6.95
Volume:N/A
Avg Vol (3m):3,086,150
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXDown 5.04%N/A
MRKN/A
NVSN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.28
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback